Published Date: 16 Feb 2023
How is the SARS-CoV-2 mRNA antibody similar to the P.1 gamma strain and other strains?
Read Full NewsNeurocrine Biosciences launches a Phase 2 trial for NBI-1065890, targeting tardive dyskinesia with promising new treatment options.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on the ACTRIMS and its history!
Anti–interleukin-6 receptor therapy may offer a new treatment option for patients with NMOSD and MOGAD who do not respond to rituximab, according to new findings.
Here's some of what is coming soon to NeurologyLive® this week.
The FDA approves the FreedomEDGE infusion platform for rozanolixizumab, enhancing treatment options for generalized myasthenia gravis in clinical settings.
Janis Miyasaki, MD, MEd, FRCPC, FAAN, a pioneer in neuropalliative care, provided clinical thoughts and perspectives on National Women Physicians Day and the ways to promote women leadership within the neurology field.
In honor of National Women Physicians Day, held February 3, 2026, a trio of women clinicians highlighted the importance of individualized care for women living with multiple sclerosis.
1.
From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study
2.
Year in Review: Multiple Myeloma
3.
Short-course radiation matches standard therapy for endometrial cancer
4.
DNA origami offers more accurate imaging in the fight against pancreatic cancer
5.
healthy despite having advanced cancer.
1.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
2.
The Different Types of Cysts and Why They Occur: Insights from a Dermatologist
3.
Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications
4.
Multimodal Data Fusion with Deep Neural Networks - Revolutionizing Oncology with Precision Cancer Diagnosis 2025
5.
Evolution of Cancer Care Through Developmental Therapeutics
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Updates on the First Line Management of ALK+ NSCLC
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation